Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Get a sneak peek inside Saffron’s highly anticipated new digs at Beyti, a pop-up dinner from chef Sameh Wadi. Taking place over two nights, March 13 and 14, Wadi and his team are welcoming guests into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results